1. Home
  2. KRMN vs ICUI Comparison

KRMN vs ICUI Comparison

Compare KRMN & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRMN
  • ICUI
  • Stock Information
  • Founded
  • KRMN 2020
  • ICUI 1984
  • Country
  • KRMN United States
  • ICUI United States
  • Employees
  • KRMN N/A
  • ICUI N/A
  • Industry
  • KRMN
  • ICUI Medical/Dental Instruments
  • Sector
  • KRMN
  • ICUI Health Care
  • Exchange
  • KRMN NYSE
  • ICUI Nasdaq
  • Market Cap
  • KRMN 3.7B
  • ICUI 3.8B
  • IPO Year
  • KRMN 2025
  • ICUI 1992
  • Fundamental
  • Price
  • KRMN $28.77
  • ICUI $141.97
  • Analyst Decision
  • KRMN
  • ICUI Buy
  • Analyst Count
  • KRMN 0
  • ICUI 4
  • Target Price
  • KRMN N/A
  • ICUI $199.67
  • AVG Volume (30 Days)
  • KRMN 1.7M
  • ICUI 237.9K
  • Earning Date
  • KRMN 01-01-0001
  • ICUI 05-06-2025
  • Dividend Yield
  • KRMN N/A
  • ICUI N/A
  • EPS Growth
  • KRMN N/A
  • ICUI N/A
  • EPS
  • KRMN 0.10
  • ICUI N/A
  • Revenue
  • KRMN $331,005,652.00
  • ICUI $2,382,046,000.00
  • Revenue This Year
  • KRMN N/A
  • ICUI N/A
  • Revenue Next Year
  • KRMN N/A
  • ICUI $3.00
  • P/E Ratio
  • KRMN $282.10
  • ICUI N/A
  • Revenue Growth
  • KRMN 24.04
  • ICUI 5.44
  • 52 Week Low
  • KRMN $27.76
  • ICUI $93.36
  • 52 Week High
  • KRMN $34.20
  • ICUI $196.26
  • Technical
  • Relative Strength Index (RSI)
  • KRMN N/A
  • ICUI 31.62
  • Support Level
  • KRMN N/A
  • ICUI $135.77
  • Resistance Level
  • KRMN N/A
  • ICUI $145.58
  • Average True Range (ATR)
  • KRMN 0.00
  • ICUI 7.07
  • MACD
  • KRMN 0.00
  • ICUI -1.55
  • Stochastic Oscillator
  • KRMN 0.00
  • ICUI 21.09

About KRMN KARMAN HOLDINGS INC

Karman Holdings Inc specializes in the upfront design, testing, manufacturing, and sale of mission-critical systems for existing and emerging missile and defense, and space programs. Its integrated payload protection, propulsion, and interstage system solutions are deployed across a wide variety of existing and emerging programs supporting important Department of Defense (DoD) and space sector initiatives. Its engineered solutions are organized into three key families: Payload Protection and Deployment Systems, Aerodynamic Interstage Systems, and Propulsion Systems. The company's solutions are deployed across three growing, core end markets: Hypersonics & Strategic Missile Defense, Missile & Integrated Defense Systems, and Space & Launch.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

Share on Social Networks: